What is Global Liver Biopsy System Market?
The Global Liver Biopsy System Market is a vast and dynamic sector that has been gaining significant attention in recent years. This market revolves around the systems and devices used to perform liver biopsies, a procedure where a small piece of liver tissue is removed for examination to detect any abnormalities or diseases. The market's value was estimated at US$ 731.8 million in 2023 and is projected to reach US$ 1026.9 million by 2030, growing at a compound annual growth rate (CAGR) of 4.9% during the forecast period from 2024 to 2030. This growth is driven by various factors such as the increasing prevalence of liver diseases, advancements in biopsy techniques, and the growing demand for minimally invasive surgeries.
Disposable Devices, Reusable Devices in the Global Liver Biopsy System Market:
The Global Liver Biopsy System Market is segmented into Disposable Devices and Reusable Devices. Disposable devices hold the largest market share, accounting for 68% of the global market. These devices are designed for single-use and are disposed of after the procedure, reducing the risk of cross-contamination. On the other hand, reusable devices are designed to be used multiple times after proper sterilization. While they may be cost-effective in the long run, they carry a higher risk of infection if not properly cleaned. The choice between disposable and reusable devices often depends on the healthcare facility's resources, patient volume, and infection control protocols.
Hospitals and Clinics, Diagnostic Centers, Other in the Global Liver Biopsy System Market:
The Global Liver Biopsy System Market finds its applications in various areas such as Hospitals and Clinics, Diagnostic Centers, and others. Hospitals and Clinics represent the largest end-use industry segment, accounting for 84% of the global market. This is primarily due to the high volume of liver biopsy procedures performed in these settings. Diagnostic Centers also make significant use of liver biopsy systems for diagnosing liver diseases. Other areas of application include research institutions and academic centers where liver biopsies may be performed for research purposes.
Global Liver Biopsy System Market Outlook:
The Global Liver Biopsy System Market outlook reveals a promising future. The market, which was valued at US$ 731.8 million in 2023, is expected to reach US$ 1026.9 million by 2030, growing at a CAGR of 4.9% during the forecast period from 2024 to 2030. Disposable Devices hold the largest market share, representing 68% of the global market. In terms of applications, Hospitals and Clinics are the largest end-use industry segment, holding 84% of the global market. North America dominates the market, holding the majority share. The leading company in the industry is BD, which holds about 54% of the global market.
| Report Metric | Details |
| Report Name | Liver Biopsy System Market |
| Accounted market size in 2023 | US$ 731.8 million |
| Forecasted market size in 2030 | US$ 1026.9 million |
| CAGR | 4.9% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Production by Region |
|
| Consumption by Region |
|
| By Company | BD, Argon Medical Devices, Cook Medical, Merit Medical, Boston Scientific, TSK, HAKKO CO., LTD., RI.MOS, Veran Medical, INRAD Inc, Sterylab, Biomedical, ZAMAR Care, Shanghai SA Medical |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
